NCT/Study#
N/A /
SIND-179041-BELANTAMAB-P-L
Single Patient Non-Emergency Use IND of Belantamab Mafodotin for Patient P-L
DISEASE GROUP:
Multiple Myeloma
current phase:
N/A
STUDY STATUS:
Enrolling
Location:
Hackensack, NJ
For More information:
